{"name":"Imvax","slug":"imvax","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOWDRBVG94RV85cFF1eGx4WTRwdkt4X2JFbEtYbGhpaFJmQ1hHRDFtN1EyLTdKMS1fSkp0X1dmU2p0X2s1ZUlETnR4YkNDT1FBNE1qN1dndjRoS2E0aHdmdXkxdlVYSm1wUjZ3bHppazItaG5HRk9ic1ZmdDkxR0IydktzS3ktLXJRTjJUWDI1cWFXWEF1dlozai1mcFBZMkpRSjZGdGNzai1IUDB2RTN0ZGJDV1IzZ0tsdDROWlFqaE9GcmQwWWVFRg?oc=5","date":"2025-12-02","type":"regulatory","source":"Fierce Biotech","summary":"Imvax takes brain cancer cell therapy to FDA, betting survival hit will overshadow primary miss - Fierce Biotech","headline":"Imvax takes brain cancer cell therapy to FDA, betting survival hit will overshadow primary miss","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBVMjI3SDVpazlGaUU3WGliUVVuNVNqQ09xbWFNdnEtVERpYlJsaVFleTNkTEhuTFg2ZFMxYTZ4MnJmdDM1eVNyaWg1cGN5R3d0S3I0?oc=5","date":"2025-12-02","type":"pipeline","source":"FirstWord Pharma","summary":"Imvax pitches OS advantage for brain cancer therapy after main goal falls short - FirstWord Pharma","headline":"Imvax pitches OS advantage for brain cancer therapy after main goal falls short","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNUnlHS1RXTTh0UnZkT1NxSFR4M3lnQjhrbmhyS1VIQS1BR0t2YVExLVlrc2JLUGpFLWQ2Sm0tSkR6ZjRsaU9TbkliQ2NzdnI2a09zNFpvSFdQWG83R0hnMEs4R3dFczQ2SzZiVzdwQ1pQNGhjVkJBaEFGRE5mYjdrYkttWkZiSU5vQ01WZjRGUEotdjdwV3V4OXRPTHRYQ1E2SzdlUUExVmRwT0tMRXVjeldqcw?oc=5","date":"2025-12-02","type":"pipeline","source":"statnews.com","summary":"Pharmalittle: We’re reading about hospitals suing to halt a 340B pilot, hepatitis B vaccine studies, and more - statnews.com","headline":"Pharmalittle: We’re reading about hospitals suing to halt a 340B pilot, hepatitis B vaccine studies, and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPWWs5a0RualpreExteTRQc2dEQTNrS2d2NXVPR21Hb2NJcFI5cDR3a0JFbV9BQldqb2hmUUdTRFpGZWZNOC1jQW00R2w2T1d4aDgzS3FpMTBqYV83Tlh6WGpxR0lldjRjaldMYkdBSzdwN3ZfRDVOQUc0U2dNSlh3RXZyVjNUNkxKVHBENENLWlV1NHZKZWVrSW5JQ3UySnhwZ2gwbmlZYmwzQUlO?oc=5","date":"2025-12-02","type":"trial","source":"The Business Journals","summary":"Imvax experimental brain cancer treatment shows improved patient survival in trials - The Business Journals","headline":"Imvax experimental brain cancer treatment shows improved patient survival in trials","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-01-27","type":"trial","source":"GlobeNewswire","summary":"Glioblastoma Market, an Area With High Trial Failure And - GlobeNewswire","headline":"Glioblastoma Market, an Area With High Trial Failure And","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPTXBRY3N3MTBQc083NUk5dXJtWkxsR05lTjB2Skx0TjQ5S3BkR3o3ZGpUNWwzS2NQTEViRHhnVHppdHVZSUJpWDJ6eXBqNzBtdW4wbEIyM1JIMmVCck44Q3dKRWp1T0tQY090QXdYMXU0bDNXdnlUNHlLMWxud004QXA0NEpyMERaSGYzVHA4RUdaUQ?oc=5","date":"2023-09-06","type":"pipeline","source":"Business Wire","summary":"Imvax Provides Corporate Update - Business Wire","headline":"Imvax Provides Corporate Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFB1c1k3QlIyX250OWE0UXd5ZkJsdjlkU1lSX2d3d05UclRBekNISHhTLXJjeURpU2dtRzFXV1FyM2h1UVNkelNybFc4R1Z5TXgyQklxaE9vb2RTZHZaSThwS2YxRWNTaWIw?oc=5","date":"2021-10-12","type":"pipeline","source":"Pharmaceutical Executive","summary":"Leading Through Transition - Pharmaceutical Executive","headline":"Leading Through Transition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPTk9rZE5FVEVWTHMxY2dmS1NLOGNXQjFVNlZ1TDBpNUhaUEw5OHF1M3BURUVTZEFnQkFQelRnTUttb2M1TjE2NDhqcUt5U1oyLU0teVB1d2QtUGZGc3JVekMwUnRkX1h0UC1KVEJZOTlEbzRfR1MzM0ljTGFvTi12b055Ql93NVhUWTdZN0FpdG1tejUyWC1EZ3Ayb185TFhs?oc=5","date":"2021-04-08","type":"pipeline","source":"Contract Pharma","summary":"Imvax Appoints Sean Hemingway Chief Operating Officer - Contract Pharma","headline":"Imvax Appoints Sean Hemingway Chief Operating Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOeGpUOFozclZ2d25BVjFyNTF2NjgxWG4yXzVOUW01RW5VSXk4Sld3YmljcmRIcHZrZjlvekFNVDRzVXNUVkdWZDI1WmtTdVhtbzlodTNjWk9hWVMweWxTMVlKeUdiVkk4Y0pvQVMybmdGT0M3TGNTMm14SXZQUnA2ZVB3?oc=5","date":"2020-09-28","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech's 2020 Fierce 15 - Fierce Biotech","headline":"Fierce Biotech's 2020 Fierce 15","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNSl95Tjd6UWlzcWMzcVY2U0ZabVFTNHBNV2dUUHNGaXhqeHFrdm11WHJWcWpnTEIyOTYxMV85RkVCb1JwRm1lNGNxTTdHQ2theVdhMi1NcnJzNkZnaFJ3SXVyVklxb0lLb1BsNzBOY19iVHAtV0trakZ6QWh1cTRhYUtjRERsNDZTaFp6MzV4amJHZWFQRkU4?oc=5","date":"2020-07-16","type":"pipeline","source":"Fierce Biotech","summary":"Imvax raises $112M to advance brain cancer cell therapy - Fierce Biotech","headline":"Imvax raises $112M to advance brain cancer cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPa19uR2FOaGR5cjhlWmFKSHlLWVR4b0tYdUNEVkZiSW1zLTJHVFYxLTkxWW0xOUM2X0ZnYXY5Wm12SmgxSVp6NkVkYnFmUVJ2UnhpUnQtdUJkUnhOQ2lXZVpqbVhmYmkxOUg1R3hPZ09FWjBweWI2c2tZVUpMUTltUjA4dw?oc=5","date":"2019-09-11","type":"pipeline","source":"Philadelphia Magazine","summary":"Former Spark Therapeutics COO Appointed CEO of Imvax - Philadelphia Magazine","headline":"Former Spark Therapeutics COO Appointed CEO of Imvax","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}